Skip to content
Governance Register

← US public companies

Syndax Pharmaceuticals Inc

SEC CIK 1395937 · SNDX · last insider filing 2026-06-12

Directors (from insider filings)

NameCapacity as filedFilings
Metzger Michael A Director · President and COO filed 2016 - 2026
Podlesak Dennis Director filed 2016 - 2026
Katkin Keith Director filed 2017 - 2026
Legault Pierre Director filed 2017 - 2026
Huber Martin H. Jr. Director filed 2021 - 2026
Jarrett Jennifer Director filed 2018 - 2026
Rizo Aleksandra Director filed 2024 - 2026
Meury William Director filed 2018 - 2025
Morrison Briggs Director · President, Head of R&D filed 2016 - 2024
Egros Fabrice Director filed 2016 - 2022
Shea Richard P Director · Chief Financial Officer filed 2016 - 2020
Evnin Luke Director filed 2016 - 2018
Chen Henry Director filed 2016 - 2018
Sledge George W. Jr. Director filed 2016 - 2017
Royston Ivor Director filed 2016 - 2017
Kamdar Kim P. Director filed 2016 - 2016
DP VI Associates, L.P. Director filed 2016 - 2016

Officers (from insider filings)

NameTitle as filedFilings
Botwood Nicholas A.J. Head of R&D, CMO filed 2025 - 2026
Goldan Keith A. Chief Financial Officer filed 2022 - 2026
Gallagher Neil President, Head of R&D filed 2023 - 2025
Ordentlich Peter Chief Technology Officer filed 2016 - 2023
Nolte Alexander Chief Accounting Officer filed 2021 - 2023
Madigan Catherine Chief Medical Officer filed 2022 - 2023
Sabus Steve M Chief Commercial Officer filed 2022 - 2022
Meyers Michael L. SVP, Chief Medical Officer filed 2016 - 2022
Karydas Daphne Chief Financial Officer filed 2020 - 2021
Shaw Allan Chief Financial Officer filed 2016 - 2016

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.